Genetic testing company 23andMe's bankruptcy has led to a new consumer privacy issue: what happens to the DNA of millions of ...

The direct-to-consumer DNA testing service 23andMe filed for bankruptcy earlier this month, putting millions of customers' ...

Pharmaceutical companies and precision medicine companies could also use the data to develop new drugs. It wouldn’t be the ...

LENZ Therapeutics, Inc.'s LNZ100 eye drops show strong phase 3 results for presbyopia, outperforming competitors. Click here ...

Positive azenosertib clinical data demonstrated clinically meaningful results in patients with Cyclin E1+ platinum-resistant ovarian cancer ...

Milestone Pharmaceuticals faces a pivotal FDA PDUFA decision for etripamil in PSVT. Read here for a detailed investment ...

In this edition of “Psychedelic”, The Fly conducted an exclusive interview with Mark Haden, vice president of business development at Clearmind ...

Shimla: A total of 1,471 drugs samples manufactured in Himachal Pradesh have failed quality tests over the past two years till February 25, 2025, prompting legal action against six companies, Health ...

Samuel S Chowdhury, chairman of Square Pharmaceuticals, yesterday expressed his willingness to purchase 15 lakh shares of the company, valued at over Tk 32 crore at the current market price.

After Gilead Sciences' lenacapavir made waves with stellar clinical results as a twice-yearly HIV prevention candidate, the drug has shown promise being dosed even further apart at only once a year.

Pharmaceutical giants such as J&J, Merck, and Eli Lilly are embracing AI and prioritizing upskilling. They hope that training thousands of employees on generative AI will boost productivity in ...